VEGFA and myocardial infarction: Study has revealed a mechanism for amplifying the biological activity of EVs, in which CDC-EVs promote SDF1 and VEGF secretion of fibroblasts, promote angiogenesis, and reduce scar quality after MI by promoting phenotypic transformation from inert fibroblasts to therapeutic active cells (93).